ERIKA LOPPATTO: Open Payments
NPI 1255943593 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 25 payments from 18 companies in 2025. Trend: 2023 $443 · 2024 $412 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 1 | $97 |
| Neurocrine BioSciences, Inc. | 1 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Novo Nordisk Inc | 2 | $44 |
| ABBVIE INC. | 2 | $41 |
| Cranial Technologies, Inc | 2 | $39 |
| Exact Sciences Corporation | 1 | $35 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| PFIZER INC. | 2 | $29 |
| Gilead Sciences, Inc. | 1 | $27 |
Products named: VOQUEZNA, INGREZZA, Ozempic, Doc Band, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, BREZTRI, MAVYRET.
Industry payments across MD — which companies pay providers there.
